Trial Profile
A Randomized, Four-way Crossover Pilot Study to Compare the Relative Bioavailability of Two Prototype Once-a-day Trazodone Hydrochloride Products and Two Marketed Reference Products Following an Equivalent Daily Dose Administration Under Fasting Conditions in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2012
Price :
$35
*
At a glance
- Drugs Trazodone (Primary)
- Indications Anxiety disorders; Depression
- Focus Pharmacokinetics
- Sponsors Altus Formulation Inc
- 14 May 2010 New trial record